Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 308, 120-129
Abstract
No abstract availableKeywords
Funding Information
- ugc, india (42-680/2013(SR))
- DST, India (DST/SB/EMEQ-320/2014)
- DST INDIA (DST/INSPIRE Fellowship/2016/IF160364)
- ICMR, India (3/1/3/JRF-2014/HRD-100 (32508))
This publication has 32 references indexed in Scilit:
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patientsOncology Letters, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- MetaboAnalyst: a web server for metabolomic data analysis and interpretationNucleic Acids Research, 2009
- BioMagResBankNucleic Acids Research, 2007
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Discovery and development of sorafenib: a multikinase inhibitor for treating cancerNature Reviews Drug Discovery, 2006
- Nitric oxide in liver injuryHepatology, 1999
- 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissueNMR in Biomedicine, 1994